CryoSpray Ablation (TM) GI Patient Registry
The proposed registry is a prospective, multi-center study of patients that are being
currently undergoing CryoSpray Ablation™. It will also be used to catalogue retrospective
data from records of patients already treated with the device. A maximum of 40
investigational sites will participate in this study.
Observational Model: Case-Only
Primary objectives of the study are to enable analysis of patient outcomes 2 years after final treatment and report on the effectiveness of the device in eradicating, decreasing or downgrading of the lesions.
2 years post treatment
Paul Manburg, PhD
CSA Medical, Inc.
United States: Institutional Review Board
|Cleveland Clinic Foundation||Cleveland, Ohio 44195|
|Rhode Island Hospital||Providence, Rhode Island 02903|
|University of Maryland Medical Center||Baltimore, Maryland 21201-1595|
|The Scripps Research Institute||LaJolla, California 92037|
|Syosset Hospital||Lake Success, New York 10042|
|University of North Carolina-Chapel Hill||Chapel Hill, North Carolina 27599|